BRN vs EQNR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Barnwell Industries exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across nearly all health metrics. The company is suffering from a significant revenue contraction of 30.20% YoY and deep negative profitability, with an ROE of -71.16%. While the balance sheet is remarkably clean with a Debt/Equity ratio of 0.01, this lack of leverage cannot offset the operational collapse and consistent long-term price erosion. The combination of negative margins and bearish insider activity suggests a high-risk profile with no immediate catalyst for recovery.
Equinor exhibits a stable financial foundation with a Piotroski F-Score of 6/9, but it is currently trading at a severe premium to its deterministic value. The current price of $37.94 is more than double the Graham Number ($18.78) and nearly triple the growth-based intrinsic value ($13.58). This valuation gap is compounded by sharply negative growth metrics, including a 27.3% YoY decline in earnings and a 0/100 bearish technical trend. While the balance sheet is healthier than the sector average, the combination of valuation overshoot and deteriorating fundamentals suggests significant downside risk.
Compare Another Pair
Related Comparisons
BRN vs EQNR: Head-to-Head Comparison
This page compares Barnwell Industries, Inc. (BRN) and Equinor ASA (EQNR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.